Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine: II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment
- 30 September 1991
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 113 (3), 277-290
- https://doi.org/10.1016/0014-4886(91)90017-7
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway—II. Differential localization of dopamine and cholecystokinin receptorsNeuroscience, 1988
- Striatal D1 dopamine receptor distribution following chemical lesion of the nigrostriatal pathwayBrain Research, 1988
- Age-related differential recovery rates of rat striatal D-1 dopamine receptors following irreversible inactivationEuropean Journal of Pharmacology, 1988
- D1 and D2 dopamine binding site up-regulation and apomorphine-induced stereotypyPharmacology Biochemistry and Behavior, 1987
- Axonal transport of dopamine D1 receptors in the rat brainBrain Research, 1987
- Comparison of dopamine binding sites in the rat superior cervical ganglion and caudate nucleusBrain Research, 1987
- D-1 dopamine receptor changes after striatal quinolinic acid lesionEuropean Journal of Pharmacology, 1987
- Picomolar affinity of 125I-SCH 23982 for D1 receptors in brain demonstrated with digital subtraction autoradiographyJournal of Neuroscience, 1987
- Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brainJournal of Neuroscience, 1986
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977